about
Effects of Beta-Blocker Withdrawal in Acute Decompensated Heart Failure: A Systematic Review and Meta-AnalysisWorld Health Organization Group I Pulmonary Hypertension: Epidemiology and Pathophysiology.The Critical Role of Pulmonary Arterial Compliance in Pulmonary Hypertension.Quadriceps myopathy caused by skeletal muscle-specific ablation of β(cyto)-actinAssessing continuous renal replacement therapy as a rescue strategy in cardiorenal syndrome 1.Microtubule-Mediated Misregulation of Junctophilin-2 Underlies T-Tubule Disruptions and Calcium Mishandling in mdx Mice.Context-dependent functional substitution of alpha-skeletal actin by gamma-cytoplasmic actin.Dystrophin is a microtubule-associated protein.Pulmonary pulse wave transit time is associated with right ventricular-pulmonary artery coupling in pulmonary arterial hypertension.Pulmonary hypertension secondary to heart failure with preserved ejection fraction.Chronic use of PAH-specific therapy in World Health Organization Group III Pulmonary Hypertension: a systematic review and meta-analysisColchicine Depolymerizes Microtubules, Increases Junctophilin-2, and Improves Right Ventricular Function in Experimental Pulmonary Arterial Hypertension.Interleukin-6 is independently associated with right ventricular function in pulmonary arterial hypertension.Disproportionate Right Ventricular Dysfunction and Poor Survival in Group 3 Pulmonary Hypertension.Survival in pulmonary hypertension due to chronic lung disease: Influence of low diffusion capacity of the lungs for carbon monoxideClinical Determinants and Prognostic Implications of Right Ventricular Dysfunction in Pulmonary Hypertension Caused by Chronic Lung DiseaseHypochloremia Is a Noninvasive Predictor of Mortality in Pulmonary Arterial HypertensionRepurposing Medications for Treatment of Pulmonary Arterial Hypertension: What's Old Is New AgainExacerbation of dystrophic cardiomyopathy by phospholamban deficiency mediated chronically increased cardiac Ca2+ cycling in vivoDouble Rule In: Concomitant Acute Coronary Occlusion and Pulmonary EmbolismEXPRESS: Transition from Parental Prostacyclin to Selexipag: A Case Series of Five Pulmonary Arterial Hypertension Patients
P50
Q26801321-07EF4BBA-219A-41FF-9FFF-D94D0F6229C0Q30248878-6DDF62C4-EE05-47CF-AB20-E841E8DAE03DQ33772330-7889255D-BE95-4E94-9EC9-310F7E833A90Q34625134-78371D19-94FC-46B8-A34D-D0FBC30E4812Q35026473-56ADF810-0B1D-4213-8E72-14DC75090ED1Q37137350-8EA02256-EBB5-49FD-BD01-6885621486FCQ37247498-5FDB6114-DACC-4866-8E63-17B1E2C9B15BQ37309139-96487840-CB43-433D-A06C-067DE6FEEDCAQ37555462-71BD73CA-5C9E-4C5F-9468-22971DD7A379Q38404276-F66B6472-1A98-468C-AC2E-AFBC519D1CF9Q38662320-DB588791-D193-4E14-AB31-EEDBEE8DDF5AQ47155453-18A6ADC6-87DE-4AAA-BE11-06A8C1E94F3AQ48001652-5558FE51-9BA4-4779-91BF-A409711FBE70Q49842224-206954AB-84C6-4925-BCD6-BE888AE39CF9Q58554743-581288D6-091F-41B6-80DF-F2DB7D7372B9Q64239294-C8131DDE-24FE-4430-BB9F-8933BA4A3F20Q89807086-9601607F-F3F4-4AD2-A34C-259DD2F49D4CQ90781750-2A56FA2C-5187-4C8F-AE83-2F28EFFF78D8Q91002165-95066E99-5007-451D-B10B-127DFD531A5FQ92135523-7E54686F-225A-49D6-A573-8CD8D76ABE4DQ92870356-2F5EB86B-2788-4B91-BDD4-AAE3479C046E
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Kurt W Prins
@en
Kurt W Prins
@nl
type
label
Kurt W Prins
@en
Kurt W Prins
@nl
prefLabel
Kurt W Prins
@en
Kurt W Prins
@nl
P31
P496
0000-0002-0364-6742